Nerve stimulation for restless legs in pregnancy
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if a small nerve stimulation device can safely and effectively reduce restless legs symptoms in pregnant people. If you are between 21 and 26 weeks pregnant with a confirmed diagnosis of restless legs syndrome (RLS), you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are between 21 and 26 weeks pregnant with a single baby (no twins or known birth defects)
- You have been diagnosed with restless legs syndrome by a sleep specialist
- You can use the device at home, answer questionnaires, and attend follow-up visits up to 3 months after giving birth
- You do not have any condition that makes nerve stimulation unsafe (like a pacemaker, history of seizures, or deep vein thrombosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a device that gently stimulates a nerve on your forehead can safely treat migraines during pregnancy. You'll use the device at home and track your headaches via text or email.
This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spinal cord) can help reduce severe restless legs syndrome (RLS) symptoms that have not improved with medication. If you have severe RLS, this could be a new way to find relief.
This study tests whether a spinal cord stimulator can help people with restless leg syndrome (RLS). It compares people with RLS to healthy volunteers to see if the device reduces symptoms.
This study tests whether combining near-infrared light and vibration therapy can help people with type 2 diabetes who also have restless legs syndrome (an overwhelming urge to move the legs, especially at night). It aims to see if these gentle treatments can reduce the discomfort and improve your sleep.
This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.
Hear when a new Restless Leg Syndrome (RLS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.